UBS Knock-Out AZN/ DE000UM8QCH9 /
12/23/2024 9:50:43 AM | Chg.-0.13 | Bid10:00:19 PM | Ask10:00:19 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.23EUR | -2.98% | - Bid Size: - |
- Ask Size: - |
AstraZeneca PLC | 108.9872 USD | 12/31/2078 | Put |
Newsfile Corp
12/23
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Impo...
Newsfile Corp
12/21
ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Ac...
Newsfile Corp
12/20
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Inquire About Securities Cla...
Newsfile Corp
12/18
ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Inquire About Securities Cl...
GlobeNewswire
8/13
Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
6/20
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire
5/15
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
5/13
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/8
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
4/1
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire
3/25
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, In...
GlobeNewswire
3/25
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update